Annual Working Capital
$2.70 B
+$790.51 M+41.32%
December 31, 2022
Summary
- As of February 7, 2025, HZNP annual working capital is $2.70 billion, with the most recent change of +$790.51 million (+41.32%) on December 31, 2022.
- During the last 3 years, HZNP annual working capital has risen by +$1.74 billion (+180.78%).
Performance
HZNP Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Working Capital
$3.00 B
+$286.32 M+10.53%
June 30, 2023
Summary
- As of February 7, 2025, HZNP quarterly working capital is $3.00 billion, with the most recent change of +$286.32 million (+10.53%) on June 30, 2023.
- Over the past year, HZNP quarterly working capital has increased by +$592.25 million (+24.55%).
Performance
HZNP Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
HZNP Working Capital Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +41.3% | +24.6% |
3 y3 years | +180.8% | +495.6% |
5 y5 years | +471.4% | +490.3% |
HZNP Working Capital Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | -29.2% | at high | -36.3% |
5 y | 5-year | at high | -64.4% | at high | -83.2% |
alltime | all time | at high | -100.7% | at high | -100.8% |
Horizon Therapeutics Public Limited Working Capital History
Date | Annual | Quarterly |
---|---|---|
Jun 2023 | - | $3.00 B(+10.5%) |
Mar 2023 | - | $2.72 B(+0.5%) |
Dec 2022 | $2.70 B(+41.3%) | $2.70 B(+6.0%) |
Sep 2022 | - | $2.55 B(+5.8%) |
Jun 2022 | - | $2.41 B(+13.6%) |
Mar 2022 | - | $2.12 B(+10.9%) |
Dec 2021 | $1.91 B(-12.8%) | $1.91 B(+22.7%) |
Sep 2021 | - | $1.56 B(+17.9%) |
Jun 2021 | - | $1.32 B(+25.1%) |
Mar 2021 | - | $1.06 B(-51.8%) |
Dec 2020 | $2.19 B(+127.9%) | $2.19 B(+12.6%) |
Sep 2020 | - | $1.95 B(+286.3%) |
Jun 2020 | - | $504.43 M(-38.6%) |
Mar 2020 | - | $821.31 M(-14.7%) |
Dec 2019 | $962.93 M(+15.0%) | $962.93 M(+14.2%) |
Sep 2019 | - | $843.19 M(+10.3%) |
Jun 2019 | - | $764.67 M(+15.1%) |
Mar 2019 | - | $664.34 M(-20.6%) |
Dec 2018 | $837.13 M(+76.9%) | $837.13 M(+29.3%) |
Sep 2018 | - | $647.62 M(+27.2%) |
Jun 2018 | - | $508.97 M(+19.5%) |
Mar 2018 | - | $425.89 M(-10.0%) |
Dec 2017 | $473.20 M(+7.4%) | $473.20 M(+4.3%) |
Sep 2017 | - | $453.67 M(+8.3%) |
Jun 2017 | - | $418.75 M(-12.6%) |
Mar 2017 | - | $479.09 M(+8.8%) |
Dec 2016 | $440.43 M | $440.43 M(-21.6%) |
Sep 2016 | - | $561.48 M(+8.1%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2016 | - | $519.24 M(+19.7%) |
Mar 2016 | - | $433.68 M(-42.1%) |
Dec 2015 | $748.60 M(+606.1%) | $748.60 M(+18.4%) |
Sep 2015 | - | $632.04 M(+4.1%) |
Jun 2015 | - | $607.31 M(+12.6%) |
Mar 2015 | - | $539.49 M(+408.8%) |
Dec 2014 | $106.02 M(+57.2%) | $106.02 M(+25.3%) |
Sep 2014 | - | $84.61 M(-1363.6%) |
Jun 2014 | - | -$6.70 M(-107.2%) |
Mar 2014 | - | $93.25 M(+38.2%) |
Dec 2013 | $67.45 M(-15.7%) | $67.45 M(+67.1%) |
Sep 2013 | - | $40.38 M(-6.3%) |
Jun 2013 | - | $43.08 M(-26.8%) |
Mar 2013 | - | $58.85 M(-26.4%) |
Dec 2012 | $79.98 M(+7410.1%) | $79.98 M(-23.9%) |
Sep 2012 | - | $105.10 M(+129.6%) |
Jun 2012 | - | $45.77 M(-32.7%) |
Mar 2012 | - | $68.02 M(+6286.9%) |
Dec 2011 | $1.06 M(-105.9%) | $1.06 M(-95.1%) |
Sep 2011 | - | $21.95 M(-187.8%) |
Jun 2011 | - | -$24.99 M(-0.7%) |
Mar 2011 | - | -$25.17 M(+40.3%) |
Dec 2010 | -$17.94 M(+1882.8%) | -$17.94 M(+127.4%) |
Sep 2010 | - | -$7.89 M(-563.4%) |
Jun 2010 | - | $1.70 M(-114.9%) |
Mar 2010 | - | -$11.43 M(+1162.5%) |
Dec 2009 | -$905.00 K(+44.1%) | -$905.00 K |
Dec 2008 | -$628.00 K | - |
FAQ
- What is Horizon Therapeutics Public Limited annual working capital?
- What is the all time high annual working capital for Horizon Therapeutics Public Limited?
- What is Horizon Therapeutics Public Limited annual working capital year-on-year change?
- What is Horizon Therapeutics Public Limited quarterly working capital?
- What is the all time high quarterly working capital for Horizon Therapeutics Public Limited?
- What is Horizon Therapeutics Public Limited quarterly working capital year-on-year change?
What is Horizon Therapeutics Public Limited annual working capital?
The current annual working capital of HZNP is $2.70 B
What is the all time high annual working capital for Horizon Therapeutics Public Limited?
Horizon Therapeutics Public Limited all-time high annual working capital is $2.70 B
What is Horizon Therapeutics Public Limited annual working capital year-on-year change?
Over the past year, HZNP annual working capital has changed by +$790.51 M (+41.32%)
What is Horizon Therapeutics Public Limited quarterly working capital?
The current quarterly working capital of HZNP is $3.00 B
What is the all time high quarterly working capital for Horizon Therapeutics Public Limited?
Horizon Therapeutics Public Limited all-time high quarterly working capital is $3.00 B
What is Horizon Therapeutics Public Limited quarterly working capital year-on-year change?
Over the past year, HZNP quarterly working capital has changed by +$592.25 M (+24.55%)